Quantitative Systematic Strategies LLC grew its position in shares of Allstate Corp (NYSE:ALL) by 208.9% in the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 26,472 shares of the insurance provider’s stock after buying an additional 17,903 shares during the quarter. Quantitative Systematic Strategies LLC’s holdings in Allstate were worth $2,493,000 as of its most recent filing with the SEC.
Other institutional investors have also recently made changes to their positions in the company. Ipswich Investment Management Co. Inc. acquired a new position in shares of Allstate during the fourth quarter valued at $25,000. 1 North Wealth Services LLC acquired a new stake in Allstate in the fourth quarter worth about $25,000. We Are One Seven LLC acquired a new stake in Allstate in the fourth quarter worth about $27,000. Legacy Advisors LLC acquired a new stake in Allstate in the first quarter worth about $29,000. Finally, Executive Wealth Management LLC acquired a new stake in Allstate in the fourth quarter worth about $32,000. Institutional investors own 79.39% of the company’s stock.
Several equities research analysts recently weighed in on ALL shares. Zacks Investment Research downgraded shares of Allstate from a “strong-buy” rating to a “hold” rating in a report on Friday, January 18th. Compass Point started coverage on shares of Allstate in a report on Tuesday, January 15th. They issued a “buy” rating and a $114.00 price objective for the company. Wells Fargo & Co reaffirmed a “hold” rating and issued a $94.00 price objective on shares of Allstate in a report on Tuesday, March 12th. William Blair upgraded shares of Allstate from an “underperform” rating to a “market perform” rating in a research report on Wednesday, February 6th. Finally, ValuEngine upgraded shares of Allstate from a “sell” rating to a “hold” rating in a research report on Monday, February 4th. Ten equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $101.91.
Allstate (NYSE:ALL) last announced its earnings results on Wednesday, May 1st. The insurance provider reported $2.30 EPS for the quarter, topping the consensus estimate of $2.28 by $0.02. The company had revenue of $8.70 billion for the quarter, compared to analysts’ expectations of $8.82 billion. Allstate had a return on equity of 12.66% and a net margin of 6.26%. The business’s revenue for the quarter was up 6.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.96 earnings per share. As a group, equities analysts predict that Allstate Corp will post 8.99 EPS for the current year.
WARNING: This report was first posted by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this report on another website, it was copied illegally and reposted in violation of US & international copyright and trademark law. The original version of this report can be accessed at https://www.baseballdailydigest.com/news/2019/05/08/quantitative-systematic-strategies-llc-has-2-49-million-holdings-in-allstate-corp-all.html.
The Allstate Corporation, through its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection, Service Businesses, Allstate Life, and Allstate Benefits segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal lines products, such as renter, condominium, landlord, boat, umbrella, and manufactured home insurance; and commercial lines products under the Allstate, Esurance, and Encompass brand names.
Read More: What is a short straddle?
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.